News

Keep up to date with our business activities by reading our news.

20 March 2023

Ascend launches with over $130M of funding as expert teams merge

Ascend Gene & Cell Therapies (Ascend), a specialist company innovating manufacturing processes to improve quality, potency, safety and cost...

Read More